Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

MicroRNAs in Colon Tissue of Pediatric Ulcerative Pancolitis Patients Allow Detection and Prognostic Stratification

P. Jabandziev, T. Kakisaka, J. Bohosova, T. Pinkasova, L. Kunovsky, O. Slaby, A. Goel

. 2021 ; 10 (6) : . [pub] 20210323

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc21018113

Grantová podpora
CA184792 National Cancer Institute, National Institutes of Health
CA187956 National Cancer Institute, National Institutes of Health
CA227602 National Cancer Institute, National Institutes of Health
CA072851 National Cancer Institute, National Institutes of Health
CA202797 National Cancer Institute, National Institutes of Health
FNBr, 65269705 Ministry of Health, Czech Republic - conceptual development of research organization

Prevalence of inflammatory bowel disease has been on the rise in recent years, especially in pediatric populations. This study aimed to provide precise identification and stratification of pediatric patients with diagnosed ulcerative colitis (UC) according to the severity of their condition and the prediction for standard treatment according to the specific expression of candidate miRNAs. We enrolled consecutive, therapeutically naïve, pediatric UC patients with confirmed pancolitis. We examined formalin-fixed paraffin-embedded specimens of colonic tissue for the expression of 10 selected candidate miRNAs. We performed receiver operating characteristic curve analysis, using area under the curve and a logistic regression model to evaluate the diagnostic and predictive power of the miRNA panels. Sixty patients were included in the final analysis. As a control group, 18 children without macroscopic and microscopic signs of inflammatory bowel disease were examined. The combination of three candidate miRNAs (let-7i-5p, miR-223-3p and miR-4284) enabled accurate detection of pediatric UC patients and controls. A panel of four candidate miRNAs (miR-375-3p, miR-146a-5p, miR-223-3p and miR-200b-3p) was associated with severity of UC in pediatric patients and a combination of three miRNAs (miR-21-5p, miR-192-5p and miR-194-5p) was associated with early relapse of the disease. Nine patients out of the total were diagnosed with primary sclerosing cholangitis (PSC) simultaneously with ulcerative colitis. A panel of 6 candidate miRNAs (miR-142-3p, miR-146a-5p, miR-223-3p, let-7i-5p, miR-192-5p and miR-194-5p) identified those patients with PSC. Specific combinations of miRNAs are promising tools for potential use in precise disease identification and severity and prognostic stratification in pediatric patients with ulcerative pancolitis.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21018113
003      
CZ-PrNML
005      
20210729104133.0
007      
ta
008      
210726s2021 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/jcm10061325 $2 doi
035    __
$a (PubMed)33806966
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Jabandziev, Petr $u Department of Pediatrics, University Hospital Brno, Faculty of Medicine, Masaryk University, 613 00 Brno, Czech Republic $u Central European Institute of Technology, Masaryk University, 625 00 Brno, Czech Republic
245    10
$a MicroRNAs in Colon Tissue of Pediatric Ulcerative Pancolitis Patients Allow Detection and Prognostic Stratification / $c P. Jabandziev, T. Kakisaka, J. Bohosova, T. Pinkasova, L. Kunovsky, O. Slaby, A. Goel
520    9_
$a Prevalence of inflammatory bowel disease has been on the rise in recent years, especially in pediatric populations. This study aimed to provide precise identification and stratification of pediatric patients with diagnosed ulcerative colitis (UC) according to the severity of their condition and the prediction for standard treatment according to the specific expression of candidate miRNAs. We enrolled consecutive, therapeutically naïve, pediatric UC patients with confirmed pancolitis. We examined formalin-fixed paraffin-embedded specimens of colonic tissue for the expression of 10 selected candidate miRNAs. We performed receiver operating characteristic curve analysis, using area under the curve and a logistic regression model to evaluate the diagnostic and predictive power of the miRNA panels. Sixty patients were included in the final analysis. As a control group, 18 children without macroscopic and microscopic signs of inflammatory bowel disease were examined. The combination of three candidate miRNAs (let-7i-5p, miR-223-3p and miR-4284) enabled accurate detection of pediatric UC patients and controls. A panel of four candidate miRNAs (miR-375-3p, miR-146a-5p, miR-223-3p and miR-200b-3p) was associated with severity of UC in pediatric patients and a combination of three miRNAs (miR-21-5p, miR-192-5p and miR-194-5p) was associated with early relapse of the disease. Nine patients out of the total were diagnosed with primary sclerosing cholangitis (PSC) simultaneously with ulcerative colitis. A panel of 6 candidate miRNAs (miR-142-3p, miR-146a-5p, miR-223-3p, let-7i-5p, miR-192-5p and miR-194-5p) identified those patients with PSC. Specific combinations of miRNAs are promising tools for potential use in precise disease identification and severity and prognostic stratification in pediatric patients with ulcerative pancolitis.
655    _2
$a časopisecké články $7 D016428
700    1_
$a Kakisaka, Tatsuhiko $u Department of Molecular Diagnostics and Experimental Therapeutics, Beckman Research Institute of City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA
700    1_
$a Bohosova, Julia $u Central European Institute of Technology, Masaryk University, 625 00 Brno, Czech Republic
700    1_
$a Pinkasova, Tereza $u Department of Pediatrics, University Hospital Brno, Faculty of Medicine, Masaryk University, 613 00 Brno, Czech Republic $u Central European Institute of Technology, Masaryk University, 625 00 Brno, Czech Republic
700    1_
$a Kunovsky, Lumir $u Department of Gastroenterology and Internal Medicine, University Hospital Brno, Faculty of Medicine, Masaryk University, 625 00 Brno, Czech Republic $u Department of Surgery, University Hospital Brno, Faculty of Medicine, Masaryk University, 625 00 Brno, Czech Republic
700    1_
$a Slaby, Ondrej $u Central European Institute of Technology, Masaryk University, 625 00 Brno, Czech Republic $u Department of Biology, Faculty of Medicine, Masaryk University, 625 00 Brno, Czech Republic
700    1_
$a Goel, Ajay $u Department of Molecular Diagnostics and Experimental Therapeutics, Beckman Research Institute of City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA
773    0_
$w MED00195462 $t Journal of clinical medicine $x 2077-0383 $g Roč. 10, č. 6 (2021)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33806966 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20210726 $b ABA008
991    __
$a 20210729104132 $b ABA008
999    __
$a ind $b bmc $g 1676540 $s 1138557
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 10 $c 6 $e 20210323 $i 2077-0383 $m Journal of clinical medicine $n J Clin Med $x MED00195462
GRA    __
$a CA184792 $p National Cancer Institute, National Institutes of Health
GRA    __
$a CA187956 $p National Cancer Institute, National Institutes of Health
GRA    __
$a CA227602 $p National Cancer Institute, National Institutes of Health
GRA    __
$a CA072851 $p National Cancer Institute, National Institutes of Health
GRA    __
$a CA202797 $p National Cancer Institute, National Institutes of Health
GRA    __
$a FNBr, 65269705 $p Ministry of Health, Czech Republic - conceptual development of research organization
LZP    __
$a Pubmed-20210726

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace